Sunny Biotechnology Co. specializes in the development of a range of biotechnological products, particularly focusing on antibodies and media for life science research. The company offers both polyclonal and monoclonal antibodies, including secondary antibodies that are conjugated with enzymes or biotin, as well as DyLight® fluorescent secondary antibodies. These products are designed for various applications such as immunoassays and fluorescence microscopy. The antibodies are affinity-purified using immunoaffinity chromatography, which enhances their specificity and reduces non-specific background staining, making them suitable for high-precision research and diagnostic purposes.

In addition to its antibody offerings, Sunny Biotechnology provides serum-free media and supplements tailored for stem cell research, along with peptide synthesis services. The company is committed to innovation, having developed a new generation of monoclonal antibodies aimed at both biomedical research and clinical diagnostics. Furthermore, they are expanding their services to include custom antibody development, particularly focusing on fully human monoclonal therapeutic antibody screening. This comprehensive approach underscores Sunny Biotechnology's dedication to advancing life sciences through sustainable and impactful biotechnological solutions.

United States

Sunny Biotechnology Co focuses on the development of polyclonal, monoclonal, secondary antibodies, serum-free media and supplements for stem cell research, peptide synthesis service, and related biotech products for life science research and clinical diagnosis.

Sunny Biotechnology

Company Details